Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

EXPLAINED: Bio techne stock is wall street bullish or bearish | Vintage Vibes

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets. With a market cap of $9.6 billion, Bio-Techne operates through Protein Sciences & Diagnostics and Genomics segments.

The biotech major has significantly underperformed the broader market over the past year. Bio-Techne stock prices declined 15.7% in 2025 and plunged nearly 20% over the past year, compared to the S&P 500 Index’s ($SPX) 14.6% gains in 2025 and 12.6% returns over the past year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.